Fusion Antibodies - Placing to Raise £3m

Paul Kerr, CEO of Fusion Antibodies, talks about the company's recent placing to raise £3m along with an update around Covid-19 and plans for the rest of the year.

Paul Kerr
Chief Executive Officer

Company Events - FUSION ANTIBODIES PLC

Fusion Antibodies - Placing to Raise £3m

Paul Kerr, Chief Executive Officer

Wed, 6 May 2020, 8:10am BST

Fusion Antibodies - Market Open

Paul Kerr, Chief Executive Officer

Tue, 19 Dec 2017, 12:36pm GMT